Tryptase as an inflammatory marker in allergic disease and asthma

References

• Tattersfield AE. Asthma. Lancet 360, 1313–1322 (2002).
   PubMed Web of Science ®Google Scholar
• Busse WW. Asthma. N. Engl. J. Med. 344, 350–362 (2001).
   PubMed Web of Science ®Google Scholar
• Nicolai T. The epidemiology of asthma and allergic diseases: a comparison between Eastern and Western European countries. Pediatr. Pulmonol. S23, 27–29 (2001).
   PubMed Web of Science ®Google Scholar
• Djukanovic R, Roche WR, Wilson JW et al. Mucosal inflammation in asthma. Am. Rev. Respir. Dis. 142, 434–457 (1990).
   PubMed Web of Science ®Google Scholar
• O’Byrne PM, Inman MD, Parameswaran K. The trials and tribulations of IL-5, eosinophil and allergic asthma, J. Allergy Clin. Immunol. 108, 503–508 (2001).
   PubMed Web of Science ®Google Scholar
• Leong KP, Huston DP. Understanding the pathogenesis of allergic asthma using mouse models. Ann. Allergy Asthma Immunol. 87, 96–109 (2001).
   PubMed Web of Science ®Google Scholar
• Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Ann. Rev. Immunol. 17, 255–281 (1999).
   PubMed Web of Science ®Google Scholar
• Makker HK. Investigative use of fibreoptic bronchoscopy for local airway challenge in asthma. Eur. Respir. J. 6, 1402–1408 (1993).
   PubMed Web of Science ®Google Scholar
• Lloyd CM. Mouse models of allergic airway disease. Adv. Immunol. 77, 263–295 (2001).
   PubMed Web of Science ®Google Scholar
• Wardlaw AJ. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyper-reactivity. Am. Rev. Respir. Dis. 137, 62–69 (1988).
   PubMed Web of Science ®Google Scholar
• Broide DH, Firestein GS. Endobronchial allergen challenge in asthma. J. Clin. Invest. 88, 1048–1053 (1991).
   PubMed Web of Science ®Google Scholar
• Lam S. Cellular and protein changes in bronchial lavage fluid after late asthmatic reaction in patients with red cedar asthma. J. Allergy Clin. Immunol. 80, 44–50 (1987).
   PubMed Web of Science ®Google Scholar
• Beasley R. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am. Rev. Respir. Dis. 139, 806–817 (1989).
   PubMed Web of Science ®Google Scholar
• De Monchy JG. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am. Rev. Respir. Dis. 131, 373–376 (1985).
   PubMed Web of Science ®Google Scholar
• Fukuda T. Increased numbers of hypodense eosinophils in the blood of patients with bronchial asthma. Am. Rev. Respir. Dis.132, 981–985 (1985).
   PubMedGoogle Scholar
• Frick WE. The appearance of hypodense eosinophils in antigen-dependent late phase asthma. Am. Rev. Respir. Dis. 139, 1401–1406 (1989).
   PubMedGoogle Scholar
• Gleich GJ. The eosinophil as a mediator of damage to respiratory epithelium, a model for bronchial hyper-reactivity. J. Allergy Clin. Immunol. 81, 776–781 (1988).
   PubMed Web of Science ®Google Scholar
• Walker C. Activated T-cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J. Allergy Clin. Immunol. 88, 935–942 (1991).
   PubMed Web of Science ®Google Scholar
• Bousquett J. Eosinophilic inflammation in asthma. N. Engl. J. Med. 323, 1033–1039 (1990).
   PubMed Web of Science ®Google Scholar
• Broide DH. Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway. J. Allergy Clin. Immunol. 88, 637–648 (1991).
   PubMed Web of Science ®Google Scholar
• Bochner BS. Immunological aspects of allergic asthma. Ann. Rev. Immunol. 12, 295–335 (1994).
   PubMed Web of Science ®Google Scholar
• Wilson JW. The measurement of reticular basement membrane and submucosal collagen in the asthmatic airway. Clin. Exp. Allergy 27, 363–371 (1997).
   PubMed Web of Science ®Google Scholar
• Muro S. The pathology of chronic asthma. Clin. Chest Med. 21, 225–244 (2000).
   PubMed Web of Science ®Google Scholar
• Barnes PJ. New directions in allergic diseases, mechanism-based anti-inflammatory therapies. J. Allergy Clin. Immunol. 106, 5–16 (2000).
   PubMed Web of Science ®Google Scholar
• Broide DH. Molecular and cellular mechanisms of allergic disease. J. Allergy Clin. Immunol. 108, S65–S71 (2001).
   PubMed Web of Science ®Google Scholar
• Humbles AA. A role for the C3a anaphylatoxin receptor in the effector phase of asthma. Nature 406, 998–1001 (2000).
   PubMed Web of Science ®Google Scholar
• Temkin V. Tryptase activates the mitogen-activated protein kinase/activator protein-1 pathway in human peripheral blood eosinophils, causing cytokine production and release. J. Immunol. 169, 2662–2669 (2002).
   PubMed Web of Science ®Google Scholar
• Foster B, Schwartz LB, Devouassour G, Metcalfe DD, Prussin C. Characterization of mast-cell tryptase-expressing peripheral blood cells as basophils. J. Allergy Clin. Immunol. 109, 287–293 (2002).
   PubMed Web of Science ®Google Scholar
• Schwartz LB. Tryptase from human mast cells: biochemistry, biology and clinical utility. Monogr. Allergy 27, 90–113 (1990).
   PubMedGoogle Scholar
• Abraham WM. Tryptase: potential role in airway inflammation and remodeling. Am. J. Physiol. Lung Cell Mol. Physiol. 282, L193– L196 (2002).
   Google Scholar
• Sakai K, Ren S, Schwartz LB. A novel heparin-dependent processing pathway for human tryptase: autocatalysis followed by activation with dipeptidyl peptidase I. J. Clin. Invest. 97, 988–995 (1996).
   PubMed Web of Science ®Google Scholar
• Kido H, Fukusen K, Katunuma K. Chymotrypsin- and trypsin-type serine proteases in rat mast cells: properties and functions. Arch. Biochem. Biophys. 239, 436–443 (1985).
   PubMed Web of Science ®Google Scholar
• Fiorucci L, Erba F, Ascoli F. Bovine tryptase: purification and characterization. Biol. Chem. Hoppe Seyler 373, 483–490 (1992).
   PubMed Web of Science ®Google Scholar
• Caughey GH. Tryptase and chymase in dog mast cells. Monogr. Allergy 27, 67–89 (1990).
   PubMedGoogle Scholar
• Bousquet J, Chanez P, Lacoste JY et al. Asthma: a disease remodeling the airways. Allergy47, 3–11 (1992).
   PubMed Web of Science ®Google Scholar
• Walls AF, Bennett AR, Sueiras-Diaz J, Olsson H. The kininogenase activity of human mast cell tryptase. Biochem. Soc. Trans. 20, S260 (1992).
   Google Scholar
• Imamura T, Dubin A, Moore W, Tanaka R, Travis J. Induction of vascular permeability enhancement by human tryptase: dependence on activation of prekallikrein and direct release of bradykinin from kininogens. Lab. Invest. 74, 861–870 (1996).
   PubMed Web of Science ®Google Scholar
• Stack MS, Johnson DA. Human mast cell tryptase activates single-chain urinary-type plasminogen activator [pro-urokinase]. J. Biol. Chem. 269, 9416–9419 (1994).
   PubMed Web of Science ®Google Scholar
• Tam EK, Caughey GH. Degradation of airway neuropeptides by human lung tryptase. Am. J. Respir. Cell Mol. Biol. 3, 27–32 (1990).
   PubMed Web of Science ®Google Scholar
• Walls AF, Brain SD, Desai A et al. Human mast cell tryptase attenuates the vasodilator activity of calcitonina gene-related peptide. Biochem. Pharmacol. 43, 1243–1248 (1992).
   PubMed Web of Science ®Google Scholar
• Levi-Schaffer F, Piliponsky AM. Tryptase, a novel link between allergic inflammation and fibrosis. Trends Immunol. 24, 158–161 (2003).
   PubMed Web of Science ®Google Scholar
• Lan RS, Stewart GA, Henry PJ. Role of protease-activated receptors in airway function: a target for therapeutic intervention? Pharmacol. Ther. 95, 239–257 (2002).
   PubMed Web of Science ®Google Scholar
• Walls AF, Bennett AR, Sueiras-Diaz J, Olsson H. The kininogenase activity of human mast cell tryptase. Biochem. Soc. Trans. 20, S260 (1992).
   Google Scholar
• He S, Peng Q, Walls AF. Potent induction of a neutrophil and eosinophil-rich infiltrate in vivo by human mast-cell tryptase: selective enhancement of eosinophil recruitment by histamine. J. Immunol. 159, 6216–6225 (1997).
   PubMed Web of Science ®Google Scholar
• Compton SJ, Cairns JA, Holgate ST, Walls AF. The role of mast cell tryptase in regulating endothelial cell proliferation, cytokine release, and adhesion molecule expression: tryptase induces expression of mRNA for IL-1 β and IL-8 and stimulates the selective release of IL-8 from human umbilical vein endothelial cells. J. Immunol. 161, 1939–1946 (1998).
   PubMed Web of Science ®Google Scholar
• Cairns JA, Walls AF. Mast cell tryptase is a mitogen for epithelial cells. Stimulation of IL-8 production and intercellular adhesion molecule-1 expression. J. Immunol. 156, 275–283 (1996).
   PubMed Web of Science ®Google Scholar
• Kaminska R, Helisalmi P, Harvima RJ, Naukkarinen A, Horsmanheimo M, Harvima IT. Focal dermal-epidermal separation and fibronectin cleavage in basement membrane by human mast cell tryptase. J. Invest. Dermatol. 113, 567–573 (1999).
   PubMed Web of Science ®Google Scholar
• Stack MS, Johnson DA. Human mast cell tryptase activates single-chain urinary-type plasminogen activator (pro-urokinase). J. Biol. Chem. 269, 9416–9419 (1994).
   PubMed Web of Science ®Google Scholar
• Artuc M, Steckelings UM, Henz BM. Mast cell–fibroblast interactions: human mast cells as source and inducers of fibroblast and epithelial growth factors. J. Invest. Dermatol. 118(3), 391–395 (2002).
   PubMed Web of Science ®Google Scholar
• Frungieri MB, Albrecht M, Raemsch R, Mayerhofer A. The action of the mast cell product tryptase on cyclooxygenase-2 (COX2) and subsequent fibroblast proliferation involves activation of the extracellular signal-regulated kinase isoforms 1 and 2 (erk1/2). Cell. Signal. 17(4), 525–33 (2005).
   PubMed Web of Science ®Google Scholar
• Brown JK, Jones CA, Rooney LA, Caughey GH. Mast cell tryptase activates extracellular-regulated kinases (p44/p42) in airway smooth-muscle cells: importance of proteolytic events, time course, and role in mediating mitogenesis. Am. J. Respir. Cell Mol. Biol. 24(2), 146–154 (2001).
   PubMed Web of Science ®Google Scholar
• Brown JK, Tyler CL, Jones CA, Ruoss SJ, Hartmann T, Caughey GH. Tryptase, the dominant secretory granular protein in human mast cells, is a potent mitogen for cultured dog tracheal smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 13(2), 227–236 (1995).
   PubMed Web of Science ®Google Scholar
• Hartmann T, Ruoss SJ, Raymond WW, Seuwen K, Caughey GH. Human tryptase as a potent, cell-specific mitogen: role of signaling pathways in synergistic responses. Am. J. Physiol. 262(5 Pt 1), L528–L534 (1992).
   Google Scholar
• Garbuzenko E, Nagler A, Pickholtz D et al. Human mast cells stimulate fibroblast proliferation, collagen synthesis and lattice contraction: a direct role for mast cells in skin fibrosis. Clin. Exp. Allergy 32(2), 237–246 (2002).
   PubMed Web of Science ®Google Scholar
• Xu X, Rivkind A, Pappo O, Pikarsky A, Levi-Schaffer F. Role of mast cells and myofibroblasts in human peritoneal adhesion formation. Ann. Surg. 236(5), 593–601 (2002).
   PubMed Web of Science ®Google Scholar
• Frungieri MB, Weidinger S, Meineke V, Kohn FM, Mayerhofer A. Proliferative action of mast-cell tryptase is mediated by PAR2, COX2, prostaglandins, and PPARγ: possible relevance to human fibrotic disorders. Proc. Natl Acad. Sci. USA 99(23), 15072–15077 (2002).
   PubMed Web of Science ®Google Scholar
• Brown JK, Jones CA, Rooney LA, Caughey GH, Hall IP. Tryptase’s potent mitogenic effects in human airway smooth muscle cells are via nonproteolytic actions. Am. J. Physiol. Lung Cell Mol. Physiol. 282(2), L197–L206 (2002).
   PubMed Web of Science ®Google Scholar
• Valent P, Horny HP, Escribano L et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk. Res. 25, 603–625 (2001).
   PubMed Web of Science ®Google Scholar
• Schwartz LB. Clinical utility of tryptase levels in systemic mastocytosis and associated hematologic disorders. Leuk. Res. 25, 553–562 (2001).
   PubMed Web of Science ®Google Scholar
• Akin C, Metcalfe DD. Surrogate markers of disease in mastocytosis. Int. Arch. Allergy Immunol. 127, 133–136 (2002).
   PubMed Web of Science ®Google Scholar
• Schwartz LB, Sakai K, Bradford TR et al. The α form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. J. Clin. Invest. 96, 2702–2710 (1995).
   PubMed Web of Science ®Google Scholar
• Sperr WR, Jordan JH, Fiegl M et al. Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease. Int. Arch. Allergy Immunol. 128, 136–141 (2002).
   PubMed Web of Science ®Google Scholar
• Sperr WR, Jordan JH, Stehberger B et al. Detection of elevated serum tryptase levels in MDS. Blood 94, 287b (1999).
   Google Scholar
• Sperr WR, Jordan JH, Baghestanian M et al. Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia. Blood 98, 2200–2209 (2001).
   PubMed Web of Science ®Google Scholar
• Deleuran B, Kristensen M, Larsen CG et al. Increased tryptase levels in suction-blister fluid from patients with urticaria. Br. J. Dermatol. 125, 14–17 (1991).
   PubMed Web of Science ®Google Scholar
• Irani AM, Gruber BL, Kaufman LD, Kahaleh MB, Schwartz LB. Mast cell changes in scleroderma. Presence of MCT cells in the skin and evidence of mast cell activation. Arthritis Rheum. 35, 933–939 (1992).
   PubMedGoogle Scholar
• Akimoto S, Ishikawa O, Igarashi Y, Kurosawa M, Miyachi Y. Dermal mast cells in scleroderma: their skin density, tryptase/ chymase phenotypes and degranulation. Br. J. Dermatol. 138, 399–406 (1998).
   PubMed Web of Science ®Google Scholar
• Amon U, Menz U, Wolff HH. Investigations on plasma levels of mast cell mediators in acute atopic dermatitis. J. Dermatol. Sci. 7, 63–67 (1994).
   PubMedGoogle Scholar
• Amon U, Memmel U, Stoll R, Amon S. Comparison of severity scoring of atopic dermatitis values and serum levels of eosinophil cationic protein and mast cell tryptase for routine evaluation of atopic dermatitis. Acta Derm. Venereol. 80, 284–286 (2000).
   PubMed Web of Science ®Google Scholar
• Dybendal T, Guttormsen AB, Elsayed S, Askeland B, Harboe T, Florvaag E. Screening for mast cell tryptase and serum IgE antibodies in 18 patients with anaphylactic shock during general anaesthesia. Acta Anaesthesiol. Scand. 47, 1211–1218 (2003).
   PubMed Web of Science ®Google Scholar
• Haeberli G, Bronnimann M, Hunziker T, Muller U. Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy. Clin. Exp. Allergy 33, 1216–1220 (2003).
   PubMed Web of Science ®Google Scholar
• Alonso Diaz de Durana MD, Fernandez-Rivas M, Casas ML, Esteban E, Cuevas M, Tejedor MA. Anaphylaxis during negative penicillin skin prick testing confirmed by elevated serum tryptase. Allergy 58, 159–163 (2003).
   PubMed Web of Science ®Google Scholar
• Schwartz LB, Yunginger JW, Miller J, Bokhari R, Dull D. Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J. Clin. Invest. 83, 1551–1555 (1989).
   PubMed Web of Science ®Google Scholar
• Horn KD, Halsey JF, Zumwalt RE. Utilization of serum tryptase and immunoglobulin E assay in the postmortem diagnosis of anaphylaxis. Am. J. Forensic Med. Pathol. 25, 37–43 (2004).
   PubMed Web of Science ®Google Scholar
• Platt MS, Yunginger JW, Sekula-Perlman A et al. Involvement of mast cells in sudden infant death syndrome. J. Allergy Clin. Immunol. 94, 250–256 (2004).
   Google Scholar
• Holgate ST, Walters C, Walls AF et al. The anaphylaxis hypothesis of sudden infant death syndrome (SIDS): mast cell degranulation in cot death revealed by elevated concentrations of tryptase in serum. Clin. Exp. Allergy 24, 1115–1122 (1994).
   PubMed Web of Science ®Google Scholar
• Buckley MG, Variend S, Walls AF. Elevated serum concentrations of β-tryptase, but not α-tryptase, in sudden infant death syndrome (SIDS). An investigation of anaphylactic mechanisms. Clin. Exp. Allergy 31, 1696–1704 (2001).
   PubMed Web of Science ®Google Scholar
• Edston E, Gidlund E, Wickman M, Ribbing H, Van Hage-Hamsten M. Increased mast cell tryptase in sudden infant death – anaphylaxis, hypoxia or artefact? Clin. Exp. Allergy 29, 1648–1654 (1999).
   PubMed Web of Science ®Google Scholar
• Nishio H, Suzuki K. Serum tryptase levels in sudden infant death syndrome in forensic autopsy cases. Forensic Sci. Int. 139, 57–60 (2004).
   PubMed Web of Science ®Google Scholar
• Benson MD, Lindberg RE. Amniotic fluid embolism, anaphylaxis, and tryptase. Am. J. Obstet. Gynecol. 175, 737 (1996).
   PubMed Web of Science ®Google Scholar
• Farrar SC, Gherman RB. Serum tryptase analysis in a woman with amniotic fluid embolism. A case report. J. Reprod. Med. 46, 926–928 (2001).
   PubMed Web of Science ®Google Scholar
• Nishio H, Matsui K, Miyazaki T, Tamura A, Iwata M, Suzuki K. A fatal case of amniotic fluid embolism with elevation of serum mast cell tryptase. Forensic Sci. Int. 126, 53–56 (2002).
   PubMed Web of Science ®Google Scholar
• Benson MD, Kobayashi H, Silver RK, Oi H, Greenberger PA, Terao T. Immunologic studies in presumed amniotic fluid embolism. Obstet. Gynecol. 97, 510–514 (2001).
   PubMed Web of Science ®Google Scholar
• He S, Aslam A, Gaca MD et al. Inhibitors of tryptase as mast cell-stabilizing agents in the human airways: effects of tryptase and other agonists of proteinase-activated receptor 2 on histamine release. J. Pharmacol. Exp. Ther. 309, 119–126 (2004).
   PubMed Web of Science ®Google Scholar
• Oh SW, Pae CI, Lee DK et al. Tryptase inhibition blocks airway inflammation in a mouse asthma model. J. Immunol. 168, 1992–2000 (2002).
   PubMed Web of Science ®Google Scholar
• Knight DA, Lim S, Scaffidi AK et al. Protease-activated receptors in human airways: upregulation of PAR-2 in respiratory epithelium from patients with asthma. J. Allergy Clin. Immunol. 108, 797–803 (2001).
   PubMed Web of Science ®Google Scholar
• Schmidlin F, Amadesi S, Dabbagh K et al. Protease-activated receptor 2 mediates eosinophil infiltration and hyper-reactivity in allergic inflammation of the airway. J. Immunol. 165, 5315–5321 (2002).
   Web of Science ®Google Scholar
• Lindner JR, Kahn ML, Coughlin SR et al. Delayed onset of inflammation in protease-activated receptor-2-deficient mice. J. Immunol. 165, 6504–6510 (2000).
   PubMed Web of Science ®Google Scholar
• Goldstein SM, Leong J, Schwartz LB, Cooke D. Protease composition of exocytosed human skin mast cell protease–proteoglycan complexes. Tryptase resides in a complex distinct from chymase and carboxypeptidase. J. Immunol.148, 2475–2482 (1992).
   PubMed Web of Science ®Google Scholar
• Alter SC, Metcalfe DD, Bradford TR, Schwartz LB. Regulation of human mast cell tryptase. Effects of enzyme concentration, ionic strength and the structure and negative charge density of polysaccharides. Biochem. J. 248, 821–827 (1987).
   PubMed Web of Science ®Google Scholar
• Ennis M, Turner G, Schock BC et al. Inflammatory mediators in bronchoalveolar lavage samples from children with and without asthma. Clin. Exp. Allergy 29, 362–366 (1999).
   PubMed Web of Science ®Google Scholar
• Schoonbrood DF, Out TA, Lutter R, Reimert CM, van Overveld FJ, Jansen HM. Plasma protein leakage and local secretion of proteins assessed in sputum in asthma and COPD. The effect of inhaled glucocorticosteroids. Clin. Chim. Acta 240, 163–178 (1995).
   PubMed Web of Science ®Google Scholar
• Pizzichini MM, Popov TA, Efthimiadis A et al. Spontaneous and induced sputum to measure indices of airway inflammation in asthma. Am. J. Respir. Crit. Care Med. 154, 866–869 (1996).
   PubMed Web of Science ®Google Scholar
• Scher H, Berman D, Weinberg EG et al. Granulocyte proteins in serum in childhood asthma: relation to spirometry and therapy. Clin. Exp. Allergy 26, 1131–1141 (1996).
   PubMed Web of Science ®Google Scholar
• Rao R, Frederick JM, Enander I, Gregson RK, Warner JA, Warner JO. Airway function correlates with circulating eosinophil, but not mast cell, markers of inflammation in childhood asthma. Clin. Exp. Allergy 26, 789–793 (1996).
   PubMed Web of Science ®Google Scholar
• Nagayama Y, Tsubaki T, Toba T, Nakayama S, Kiyofumi O. Analysis of sputum taken from wheezy and asthmatic infants and children, with special reference to respiratory infections. Pediatr. Allergy Immunol. 12, 318–326 (2001).
   PubMed Web of Science ®Google Scholar
• Bettiol J, Radermecker M, Sele J, Henquet M, Cataldo D, Louis R. Airway mast-cell activation in asthmatics is associated with selective sputum eosinophilia. Allergy 54, 1188–1193 (1999).
   PubMed Web of Science ®Google Scholar
• Louis R, Shute J, Goldring K et al. The effect of processing on inflammatory markers in induced sputum Eur. Respir. J. 13, 660–667 (1999).
   PubMed Web of Science ®Google Scholar
• Krawiec ME, Westcott JY, Chu HW et al. Persistent wheezing in very young children is associated with lower respiratory inflammation. Am. J. Respir. Crit. Care Med. 163, 1338–1343 (2001).
   PubMed Web of Science ®Google Scholar
• Klion AD, Noel P, Akin C et al. Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness. Blood 101, 4660–4666 (2003).
   PubMed Web of Science ®Google Scholar
• Schwartz LB, Yunginger JW, Miller J, Bokhari R, Dull D. Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J. Clin. Invest. 83, 1551–1555 (1989).
   PubMed Web of Science ®Google Scholar
• Salkie ML, Mitchell I, Revers CW et al. Postmortem serum levels of tryptase and total and specific IgE in fatal asthma. Allergy Asthma Proc. 19, 131–133 (1998).
   PubMed Web of Science ®Google Scholar
• Taira M, Tamaoki J, Kondo M, Kawatani K, Nagai A. Serum B12 tryptase level as a marker of allergic airway inflammation in asthma. J Asthma 39, 315–322 (2002).
   PubMed Web of Science ®Google Scholar
• Bochenek G, Nagraba K, Nizankowska E, Szczeklik A. A controlled study of 9α,11β-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge. J. Allergy Clin. Immunol. 111, 743–749 (2003).
   PubMed Web of Science ®Google Scholar
• Medrala W, Malolepszy J, Wolanczyk-Medrala A et al. Is mast cell activation during asthmatic reaction reflected in the circulation? J. Investig. Allergol. Clin. Immunol. 5, 343–346 (1995).
   PubMed Web of Science ®Google Scholar
• Gershman NH, Wong HH, Liu JT, Fahy JV. Low- and high-dose fluticasone propionate in asthma; effects during and after treatment. Eur. Respir. J.15, 11–18 (2000).
   PubMed Web of Science ®Google Scholar
• Lazarus SC, Boushey HA, Fahy JV et al. Asthma Clinical Research Network for the National Heart, Lung, and Blood Institute. Long-acting β2-agonist monotherapy vs. continued therapy with inhaled glucocorticosteroids in patients with persistent asthma: a randomized controlled trial. JAMA 285, 2583–2593 (2001).
   PubMed Web of Science ®Google Scholar
• Swystun VA, Gordon JR, Davis EB, Zhang X, Cockcroft DW. Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol. J. Allergy Clin. Immunol. 106, 57–64 (2000).
   PubMed Web of Science ®Google Scholar
• Lai CK, Chan CH, Ho SS, Hui AC, Lai KN. Inhaled salmeterol and albuterol in asthmatic patients receiving high-dose inhaled glucocorticosteroids. Chest 108, 36–40 (1995).
   PubMed Web of Science ®Google Scholar
• Tabbara KF. Tear tryptase in vernal keratoconjunctivitis. Arch. Ophthalmol. 119, 338–342 (2001).
   PubMedGoogle Scholar
• Swystun VA, Gordon JR, Davis EB, Zhang X, Cockroft DW. Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol. J. Allergy Clin. Immunol. 106, 57–64 (2000).
   PubMed Web of Science ®Google Scholar
• Sulakvelidze I, Conway M, Evans S, Stetsko PI, Djuric V, Dolovich J. Clinical and nasal irrigation fluid findings in perennial allergic rhinitis. Am. J. Rhinol. 11, 435–441 (1997).
   PubMedGoogle Scholar
• Klion AD, Noel P, Akin C et al. Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness. Blood 101, 4660–4666 (2003).
   PubMed Web of Science ®Google Scholar